Newbury Pharmaceuticals Newbury Pharmaceuticals is a pharmaceutical company for specialty prescription drugs. | |||||
Founding Date | Founding Date 2020 | Founding Date 1959 | Founding Date 1901 | Founding Date N/A | Founding Date 2018 |
Type | Type Public | Type Private | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations Lund, SE HQ | Locations Ejido, VE HQ | Locations Petah Tikva, IL HQ Villa Adelina, AR Macquarie Park, AU Minsk, BY Antwerpen, BE Sao Paulo, BR Dupnica, BG see more | Locations CL HQ | Locations HK HQ |
Employees | Employees 5 | Employees 1671% increase | Employees 37,000 | Employees 1821% decrease | Employees 498 |
Valuation ($) | Valuation ($) 9.1 m | Valuation ($) N/A | Valuation ($) 20.8 b | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) kr31.6m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $17.3b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) ¥934.9m (FY, 2025) |
Cost of goods | Cost of goods kr18.7m (FY, 2025) | Cost of goods N/A | Cost of goods $8.3b (FY, 2025) | Cost of goods N/A | Cost of goods ¥89.6m (FY, 2025) |
Gross profit | Gross profit kr12.8m (FY, 2025) | Gross profit N/A | Gross profit $8.9b (FY, 2025) | Gross profit N/A | Gross profit ¥852.5m (FY, 2025) |
Net income | Net income (kr23.9m) (FY, 2025) | Net income N/A | Net income $1.4b (FY, 2025) | Net income N/A | Net income ¥258.9m (FY, 2025) |

Laboratorios VALMOR is a manufacturer of pharmaceuticals.
View company
Teva Pharmaceuticals is a global pharmaceutical company.
View company
Lepu Biopharma is a biopharmaceutical company that focuses on oncology therapeutics.
View company